John Eichorn

It had been thought that removing the sentinel node and the surrounding lymph nodes would improve survival rates.

The NCCN voted to maintain the current recommendation and position on Avastin (bevacizumab) in its treatment of metastatic breast cancer.

Study results reveal that only a small fraction of patients with high-grade, noninvasive bladder cancer receive the appropriate treatment.

Almost 1 in 3 adults in the United States do not get screened regularly.

Patients screened with low-dose helical computed tomography (CT) reduced their risk of dying of lung cancer by 20% compared with chest x-ray.

Shortages of chemotherapy drugs continue to plague the healthcare industry.

The FDA announced that the prolonged use of pioglitazone (Actos) for more than 1 year has been linked to an increased risk of bladder cancer

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

An experimental melanoma vaccine gp100 peptide vaccine in combination with IL2 may shrink tumors and prevent the progression of late-stage melanoma

Highlights on updates to the clinical practice guidelines from the annual National Comprehensive Cancer Network (NCCN) conference

Men with advanced CRPC who were treated with abiraterone acetate plus prednisone/prednisolone had significant improvement in overall survival

Interview with Patricia Goldsmith the executive vice president and chief operating officer of the National Comprehensive Cancer Network (NCCN)

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

Crizotinib was accepted for filing by the FDA and granted Priority Review status

The risk of dying from ovarian cancer was not reduced when women received CA-125 blood testing and transvaginal ultrasound

Results from a phase III study showed that the chemotherapy combination FOLFIRINOX nearly doubled the survival time for patients with pancreatic adenocarcinoma

Reimbursement is often insufficient to cover the purchase cost of cancer drugs, forcing oncologists to pay out of pocket to treat patients

A class of drugs that has shown encouraging results in breast and ovarian cancers with BRCA gene mutations may also benefit patients who have colorectal cancers

Exposure to air pollution at certain times in a woman's life can leave her more susceptible to premenopausal breast cancer

The FDA reported today that TNF blockers may be responsible for an increased incidence of HSTCL in adolescents and young adults

The FDA has approved vandetanib for the treatment of unresectable, late-stage, metastatic medullary thyroid cancer

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop lung cancer